Alejandro Falcón
Impact in
-
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
-
- Advanced Breast Cancer Therapies
Papers in
- Oncology 18
- Lung Cancer Research Studies 9
- HER2/EGFR in Cancer Research 4
- Cancer Treatment and Pharmacology 2
-
- Lung Cancer Treatments and Mutations 6
- Advanced Breast Cancer Therapies 3
- Co-authors
- Javier Salvador Bofill (3 shared papers)María Ángeles Castilla (2 shared papers)Manuel Ruíz-Borrego (2 shared papers)Marta Benavent (3 shared papers)Sonia Molina‐Pinelo (2 shared papers)Gregory M. Coté (7 shared papers)Silvia Antolín (1 shared paper)Atanasio Pandiella (1 shared paper)
- Journals
- Journal of Clinical Oncology (9 papers)Journal of Thoracic Oncology (3 papers)International Journal of Molecular Sciences (2 papers)Cancer Research (2 papers)Clinical & Translational Oncology (2 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Alejandro Falcón
23 papers receiving 138 citations
Peers
Comparison fields: 5 of 29
- Oncology 72
- Pulmonary and Respiratory Medicine 42
- Cancer Research 17
- Genetics 9
- Molecular Biology 46
Countries citing papers authored by Alejandro Falcón
This map shows the geographic impact of Alejandro Falcón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Falcón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Falcón more than expected).
Fields of papers citing papers by Alejandro Falcón
This network shows the impact of papers produced by Alejandro Falcón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Falcón. The network helps show where Alejandro Falcón may publish in the future.
Co-authors
The 25 scholars most cited alongside Alejandro Falcón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 38 | |
| 2 | 2023 | 36 | |
| 3 | 2020 | 12 | |
| 4 | 2021 | 11 | |
| 5 | 2021 | 7 | |
| 6 | 2022 | 3 | |
| 7 | 2023 | 3 | |
| 8 | 2025 | 3 | |
| 9 | 2019 | 3 | |
| 10 | 2019 | 3 | |
| 11 | 2024 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2024 | 2 | |
| 14 | 2016 | 2 | |
| 15 | 2020 | 2 | |
| 16 | 2015 | 2 | |
| 17 | 2025 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2019 | 1 |
About Alejandro Falcón
Alejandro Falcón is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 29 papers that have together received 139 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (9 papers), Cancer therapeutics and mechanisms (6 papers), Lung Cancer Treatments and Mutations (6 papers), Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (3 papers), BRCA gene mutations in cancer (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Oncology (72 citations), Pulmonary and Respiratory Medicine (42 citations), Cancer Research (17 citations), Genetics (9 citations) and Molecular Biology (46 citations). Alejandro Falcón has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Javier Salvador Bofill, María Ángeles Castilla, Manuel Ruíz-Borrego, Marta Benavent, Sonia Molina‐Pinelo, Gregory M. Coté, Silvia Antolín, Atanasio Pandiella, Álvaro Montaño and Eva Carrasco. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, International Journal of Molecular Sciences, Cancer Research and Clinical & Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.